Only 62.4% of 16-month-old US children received the MMR vaccine from June to August, down from 72.0% before the pandemic.
Resources & Literature
Recent Literature
Banerjee E, Paul P, Griffith J, et al. Impact of isolation and exclusion as a public health strategy to contain measles virus transmission during a measles outbreak. Clin Infect Dis 2021 (published online Nov 10)
Desjardins M, Mitre X, Sherman AC, et al. Safety of live-attenuated measles, mumps, rubella vaccine administered within two years of hematopoietic cell transplant. Open Forum Infect Dis 2021 (published online Nov 23)
Dixon MG, Ferrari M, Antoni S, et al. Progress toward regional measles elimination — worldwide, 2000–2020. MMWR Morb Mortal Wkly Rep 2021 Nov 12;70:1563–1569
Gambrell A, Sundaram M, Bednarczyk RA, et al. Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines. Vaccine 2022 (published online Jun 15)
Marchi S, Remarque EJ, Viviani S, et al. Measles immunity over two decades in two large Italian regions: how far is the elimination goal? Vaccine 2021 (published online Aug 26)
Masters NB, Mathis AD, Leung J, et al. Public health actions to control measles among Afghan evacuees during Operation Allies Welcome—United States, September–November 2021. MMWR Morb Mortal Wkly Rep 2022 Apr 29;71(17):592–6
Pritchard N, Worrell MC, Shahum A, et al. Notes from the field: response to measles among persons evacuated from Afghanistan—Joint Base McGuire-Dix-Lakehurst, New Jersey, August–October 2021. MMWR Morb Mortal Wkly Rep 2022 Apr 29;71(17):609–10
Sowe A, Njie M, Sowe D, et al. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia. PLOS One 2021 (published online Oct 21)
